ODAIA Market Research Report

Company Overview

Name

ODAIA Intelligence Inc.

Mission

Reducing patients’ time to therapy by facilitating meaningful interactions with healthcare providers, through human-centric software powered by AI.

Founding Details

• Founded in: 2018

• Origin: University of Toronto

• Co-Founders:

• Helen Kontozopoulos

• Gael Bernard, PhD

• Periklis Andritsos, PhD

Key People

• Philip Poulidis: Chief Executive Officer & Co-Founder

• Zak Beharie: Chief Technology Officer

• Mark Zou: Chief Product Officer

• Laura Ricci: Chief Human Resources Officer

• Rebecca Skvorc: Chief Financial Officer

• Jim Diefenbach: Chief Revenue Officer

Headquarters

• 150 King Street West, Suite 702, Toronto, Ontario M5H 1J9

• 359 Newbury Street, Suite 500, Boston, MA 02115

Number of Employees

No information is available.

Revenue

• $12B+ revenue supported annually.

Company Recognition

ODAIA is noted for providing AI-driven insights for pharmaceutical companies, enhancing sales efficiency and meaningful engagements with healthcare providers.

Products

MAPTUAL Platform

ODAIA’s flagship platform integrates AI technologies to provide predictive insights for pharmaceutical sales teams. The platform offers several core products:

1. ODAIA Field

• Description: Provides personalized insights for pharma sales reps to optimize HCP engagements.

• Key Features:

• Intelligent HCP selection and dynamic call planning.

• Real-time insights for improved engagement timing.

2. ODAIA Field Coach

• Description: Designed to assist sales managers in leveraging personalized insights for rep coaching and performance improvements.

• Key Features:

• Real-time territory assessment.

• Personalized insights for data-driven rep development.

3. Engagement Intelligence

• Description: AI-powered insights to improve HCP interactions.

• Key Features:

• ML-driven personalized call lists.

• Generative AI pre-call insights for better engagement preparation.

4. Targeting Intelligence

• Description: Optimizes HCP targeting strategies using advanced AI.

• Key Features:

• Territory-specific HCP insights with PowerScores.

• Predictive behavioral segmentation.

Recent Developments

New Products and Features

• GenAI Integration in Veeva CRM: ODAIA introduced GenAI solutions within Veeva CRM to enhance pharma sales rep engagement efficacy.

• Targeting Intelligence Solution: Enhanced with advanced AI to enable real-time HCP targeting updates and insights.

Partnerships

• Veeva: ODAIA has partnered with Veeva to accelerate AI adoption in life sciences, becoming the first participant in the Veeva AI Partner Program.

Investments and Funding

• Series B Funding: ODAIA raised $34 million CAD ($25 million USD) to further its AI-driven commercial insights platform.

• Key Investors: Threshold Ventures and Monograph Capital.

Conclusion

ODAIA is at the forefront of using artificial intelligence to transform pharmaceutical sales and engagement strategies. Through innovative platforms like MAPTUAL, the company is driving substantial efficiency in sales operations and engagement with healthcare providers, harnessing real-time insights and predictive analytics to deliver significant business value and improved healthcare outcomes.